Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions

Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions

Lihua Wu,1,2,* Chang Xu,1,2,* Guolan Wu,1,2 Huili Zhou,1,2 Duo Lv,1,2 You Zhai,1,2 Yujie Huang,1,2 Wenling Tang,3 Fangqiong Li,4 Jianzhong Shentu1–3 1Research Center for Clinical Pharmacy, State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital...

Full description

Bibliographic Details
Main Authors: Wu L, Xu C, Wu G, Zhou H, Lv D, Zhai Y, Huang Y, Tang W, Li F, Shentu J
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Drug Design, Development and Therapy
Subjects:
bioequivalence
melitracen
flupentixol
pharmacokinetics
fixed-dose combination tablet
Online Access:https://www.dovepress.com/bioequivalence-study-of-a-fixed-dose-combination-tablet-containing-mel-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/bioequivalence-study-of-a-fixed-dose-combination-tablet-containing-mel-peer-reviewed-article-DDDT

Similar Items